Novo Nordisk Amps Up Drug Discovery with Gefion AI Supercomputer
What You Should Know:
–DCAI today announced that Novo Nordisk has become a customer of the Gefion AI supercomputer.
– Through this agreement, Novo Nordisk will gain access to Gefion’s unparalleled computational capabilities to process vast datasets, with a…
Continue Reading